MycoMed Technologies


Pearl Diagnostics is dedicated to transforming diagnostics for lung infections by developing innovative in vitro diagnostic assays that detect circulating microbial extracellular vesicles, offering early and non-invasive detection methods. The company aims to support healthcare providers with clinical tools that improve patient outcomes, especially in immunocompromised populations and those with respiratory infections.

Industries

health-care
health-diagnostics
medical

Nr. of Employees

small (1-50)

MycoMed Technologies

Baltimore, Maryland, United States, North America


Products

Urine ELISA assay for Aspergillus (96-well microplate)

A urine-based immunoassay configured as a 96-well ELISA kit for detection of Aspergillus-related urinary antigens; intended for early, non-invasive screening and laboratory testing.


Services

Technical support and customer training for diagnostic assays

Support services including troubleshooting, user training materials, and application support for laboratory and clinical users of urine diagnostic assays.

Sales and product ordering support for diagnostic kits

Commercial sales support and ordering information for diagnostic kit customers (note: products not available in the U.S.).

Expertise Areas

  • Urine-based infectious disease diagnostics
  • Immunoassay development (antibody-based assays)
  • Extracellular vesicle biomarker detection
  • High-throughput ELISA kit manufacturing
  • Show More (4)

Key Technologies

  • Microplate ELISA (96-well)
  • Lateral-flow / rapid immunoassay formats
  • Monoclonal antibody-based detection
  • Urinary antigen detection
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.